{
    "clinical_study": {
        "@rank": "154888", 
        "acronym": "CN-NINM", 
        "arm_group": [
            {
                "arm_group_label": "Active PoNS CN-NINM", 
                "arm_group_type": "Experimental", 
                "description": "Active CN-NINM PoNS - Active cranial-nerve non-invasive neuromodulation (CN-NINM) using the Portable Neuromodulation Stimulator (PoNS) and balance/gait rehabilitation with physical therapy"
            }, 
            {
                "arm_group_label": "Sham PoNS CN-NINM", 
                "arm_group_type": "Sham Comparator", 
                "description": "Sham CN-NINM PoNS - Sham cranial-nerve non-invasive neuromodulation (CN-NINM) using the Portable Neuromodulation Stimulator (PoNS) and balance/gait rehabilitation with physical therapy"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to evaluate improvement in balance after receiving physical\n      therapy when augmented by CN-NINM than when augmented by a placebo (sham CN-NINM)."
        }, 
        "brief_title": "Cranial-nerve Non-invasive Neuromodulation (CN-NINM) for Balance Deficits After Mild Traumatic Brain Injury (Full Trial)", 
        "completion_date": {
            "#text": "December 2016", 
            "@type": "Anticipated"
        }, 
        "condition": "Mild Traumatic Brain Injury", 
        "condition_browse": {
            "mesh_term": [
                "Brain Injuries", 
                "Wounds and Injuries"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. Veteran or Servicemember\n\n          2. 18 to 50 years old\n\n          3. Sustained one or more mild traumatic brain injury (mTBI)s\n\n          4. Demonstration of balance deficits on the Sensory Organization Test (a composite score\n             of 75 or less (1/3 sample) and 72 or less (2/3 sample))\n\n          5. Available for the duration of the study\n\n        Exclusion Criteria:\n\n          1. History of traumatic brain injury (TBI) of any severity other than mild TBI\n\n          2. Presence of active substance abuse condition\n\n          3. Any condition for which posturography is contraindicated (e.g. leg amputation or\n             fracture)\n\n          4. Diagnosed neurological disorder with balance sequelae, other than TBI  (e.g.\n             Parkinson's disease, incomplete spinal cord injury, or Multiple Sclerosis)\n\n          5. Orthostatic hypotension as defined by:\n\n               1. A systolic blood pressure decrease (from supine to sitting) of at least 20 mmHg\n\n               2. A diastolic blood pressure decrease of at least 10 mmHg, or\n\n               3. A pulse increase of 30 beats or more per minute with associated signs or\n                  symptoms of cerebral hypoperfusion\n\n          6. An implanted medical device\n\n          7. Pregnancy\n\n          8. Oral infection\n\n          9. Known transmissible disease (HIV, hepatitis, influenza, TB)\n\n         10. Exam signs of serious disorder other than mTBI as defined by facial asymmetry,\n             hoarseness and dysarthria (e.g. tumor, stroke)."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "50 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "56", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "April 7, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02125591", 
            "org_study_id": "CN-NINM full"
        }, 
        "intervention": [
            {
                "arm_group_label": "Active PoNS CN-NINM", 
                "description": "Delivery of active stimulation of the tongue during in-person therapy sessions (1 hour) and during two home sessions (40 minutes) daily on 6 of 7 days per week (120 total sessions). Stimulation sessions will be separated by at least 4 hours.", 
                "intervention_name": "Active CN-NINM PoNS", 
                "intervention_type": "Device", 
                "other_name": [
                    "Active cranial-nerve non-invasive neuromodulation (CN-NINM)", 
                    "Portable Neuromodulation Stimulator (PoNS)"
                ]
            }, 
            {
                "arm_group_label": "Sham PoNS CN-NINM", 
                "description": "Delivery of sham stimulation of the tongue during in-person therapy sessions (1 hour) and during two home sessions (40 minutes) daily on 6 of 7 days per week (120 total sessions). Stimulation sessions will be separated by at least 4 hours.", 
                "intervention_name": "Sham CN-NINM PoNS", 
                "intervention_type": "Device"
            }
        ], 
        "is_fda_regulated": "Yes", 
        "is_section_801": "No", 
        "keyword": "Mild Traumatic Brain Injury", 
        "lastchanged_date": "April 25, 2014", 
        "location": [
            {
                "contact": {
                    "email": "joalicea@vcu.edu", 
                    "last_name": "Justin Alicea", 
                    "phone": "804-628-1355"
                }, 
                "facility": {
                    "address": {
                        "city": "Richmond", 
                        "country": "United States", 
                        "state": "Virginia", 
                        "zip": "23298-3038"
                    }, 
                    "name": "Virginia Commonwealth University"
                }, 
                "investigator": [
                    {
                        "last_name": "William C Walker, MD", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Cheryl Ford-Smith, PhD", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Benjamin Darter, PhD", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Carolyn Graham, PhD", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Adam Sima, PhD", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Joel Steinberg, MD", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Gerry Moeller, MD", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "David X Cifu, MD", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "Tiffany.Lewis2@va.gov", 
                    "last_name": "Tiffany Lewis, MA", 
                    "phone": "804-675-5000", 
                    "phone_ext": "3654"
                }, 
                "facility": {
                    "address": {
                        "city": "Richmond", 
                        "country": "United States", 
                        "state": "Virginia", 
                        "zip": "23249"
                    }, 
                    "name": "McGuire Veterans Affairs Medical Center"
                }, 
                "investigator": [
                    {
                        "last_name": "David X Cifu, MD", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Ajit Pai, MD", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Laura M Franke, PhD", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "William C Walker, MD", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Not yet recruiting"
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "Cranial-nerve Non-invasive Neuromodulation (CN-NINM) for Balance Deficits After Mild Traumatic Brain Injury: A Randomized, Double-Blinded, Sham-Controlled, Prospective Trial", 
        "overall_contact": {
            "email": "Tiffany.Lewis2@va.gov", 
            "last_name": "Tiffany Lewis, MA", 
            "phone": "804-675-5000", 
            "phone_ext": "3654"
        }, 
        "overall_contact_backup": {
            "email": "joalicea@vcu.edu", 
            "last_name": "Justin Alicea", 
            "phone": "804-628-1355"
        }, 
        "overall_official": [
            {
                "affiliation": "VA Department of Physical Medicine and Rehabilitation", 
                "last_name": "David X Cifu, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Virginia Commonwealth University (VCU)", 
                "last_name": "William C Walker, MD", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": [
                "United States: Food and Drug Administration", 
                "United States: Federal Government"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "November 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Comparison of the SOT score between the treatment group and sham group at the intermediate follow-up.", 
            "measure": "Change in Sensory Organization Test (SOT)", 
            "safety_issue": "No", 
            "time_frame": "12 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02125591"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Change in post-concussive symptoms using Neurobehavioral Symptom Inventory (NSI)", 
                "safety_issue": "No", 
                "time_frame": "12 weeks"
            }, 
            {
                "measure": "Change in dizziness and unsteadiness measured by Dizziness Handicap Inventory (DHI)", 
                "safety_issue": "No", 
                "time_frame": "12 weeks"
            }, 
            {
                "measure": "Change in space and motion discomfort measured by Situational Characteristics Questionnaire (SitQ)", 
                "safety_issue": "No", 
                "time_frame": "12 weeks"
            }, 
            {
                "measure": "Change in quality of life measured using Short Form 36 (SF-36)", 
                "safety_issue": "No", 
                "time_frame": "12 weeks"
            }, 
            {
                "measure": "Change in symptoms of post-traumatic stress disorder (PTSD) measured using the unspecified PTSD checklist (PCL-C)", 
                "safety_issue": "No", 
                "time_frame": "12 weeks"
            }, 
            {
                "description": "DTI will be acquired using 3.0T field strength Siemens Trio MRI scanner.", 
                "measure": "Change on neural organization in tracts controlling balance using diffusion tensor imaging (DTI)", 
                "safety_issue": "No", 
                "time_frame": "12 weeks"
            }, 
            {
                "description": "For fMRI, a repeated single-shot echo-planar imaging will be acquired", 
                "measure": "Change in neuroimaging using functional magnetic resonance imaging (fMRI)", 
                "safety_issue": "No", 
                "time_frame": "12 weeks"
            }
        ], 
        "source": "U.S. Army Medical Research and Materiel Command", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "Virginia Commonwealth University", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Department of Veterans Affairs", 
                    "agency_class": "U.S. Fed"
                }, 
                {
                    "agency": "The Defense and Veterans Brain Injury Center", 
                    "agency_class": "U.S. Fed"
                }
            ], 
            "lead_sponsor": {
                "agency": "U.S. Army Medical Research and Materiel Command", 
                "agency_class": "U.S. Fed"
            }
        }, 
        "start_date": "August 2015", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}